Invention Grant
- Patent Title: Immunomodulators
-
Application No.: US17725340Application Date: 2022-04-20
-
Publication No.: US11952434B2Publication Date: 2024-04-09
- Inventor: Kevin W. Gillman , Jason Goodrich , Kenneth M. Boy , Yunhui Zhang , Claudio Mapelli , Michael A. Poss , Paul Michael Scola , David R. Langley , Nicholas A. Meanwell
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K38/00 ; A61K38/10 ; A61K45/06 ; A61K51/08 ; C07K7/56
Abstract:
The present disclosure provides compounds which are immunomodulators and thus are useful for the amelioration of various diseases, including cancer and infectious diseases.
Public/Granted literature
- US20230101323A1 IMMUNOMODULATORS Public/Granted day:2023-03-30
Information query
